Borealis Biosciences, Inc.

Borealis Biosciences, Inc.

Biotechnology Research

RNA Medicines for Kidney Disease

About us

Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.

Website
https://borealisbio.com/
Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held
Founded
2024

Employees at Borealis Biosciences, Inc.

Updates

Similar pages

Funding